Survival trends in extensive-stage small cell lung cancer in the pre-immunotherapy and immunotherapy eras: a population-based SEER study
Patients diagnosed during the immunotherapy era showed improved survival compared with those diagnosed during the pre-immunotherapy era, suggesting that personalized treatment strategies are essential for optimal patient outcomes.